{
    "title": "Organon, Samsung Bioepis launch copycat for athritis drug Humira at 85% discount",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12253851/Organon-Samsung-Bioepis-launch-copycat-athritis-drug-Humira-85-discount.html",
    "date": "2023-07-01",
    "keywords": [
        "humira",
        "discount",
        "drug",
        "drugmaker",
        "version",
        "price",
        "hadlima",
        "insurance",
        "health",
        "biosimilar",
        "wingrove",
        "july",
        "saturday",
        "market",
        "month",
        "benefit",
        "coverage",
        "abbvie",
        "coherus",
        "copycat",
        "sandoz",
        "hyrimoz",
        "biologic",
        "bioepis",
        "pharmacy",
        "behalf",
        "reimbursement",
        "corp",
        "cvsn",
        "cigna",
        "unitedhealth",
        "control",
        "healthcare",
        "percentage",
        "pbms",
        "interview",
        "officer",
        "kevin",
        "ali",
        "year",
        "race",
        "pbm",
        "food",
        "administration",
        "settlement",
        "boehringer",
        "ingelheim",
        "launch",
        "amgen",
        "january",
        "medicine",
        "buyer",
        "california",
        "partnership",
        "billionaire",
        "mark",
        "cuban",
        "company",
        "agreement",
        "license",
        "reporting",
        "editing",
        "cynthia",
        "osterman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}